An FDA panel of independent advisers is set to consider the first potential new post-traumatic stress disorder treatment in 25 years — MDMA — NBC News reported May 7.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
An FDA panel of independent advisers is set to consider the first potential new post-traumatic stress disorder treatment in 25 years — MDMA — NBC News reported May 7.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis